• Cy7 NHS Ester: Technical Guidance for Near-Infrared Labeling

  2026-05-18

  Cy7 NHS ester provides a reliable solution for labeling proteins and peptides with a hydrophilic, sulfonated near-infrared dye, minimizing denaturation risk and maximizing water solubility. It is best applied in workflows requiring sensitive, in vitro or in vivo near-infrared fluorescent imaging of biomolecules with accessible amino groups, but is not suitable for long-term dye solution storage or for targets lacking reactive amines.

• Etoposide (VP-16): Applied Workflows for Cancer Research

  2026-05-18

  Etoposide (VP-16) empowers cancer biologists to dissect DNA double-strand break pathways and apoptosis with precision. This guide translates recent discoveries, including the use of LAMP1 as a senescence marker, into actionable protocols and troubleshooting tips for DNA damage assays and senolytic strategies.

• Bufuralol Hydrochloride in Human-Relevant Cardiovascular Ass

  2026-05-17

  Explore how Bufuralol hydrochloride, a non-selective β-adrenergic receptor antagonist, transforms human-relevant cardiovascular pharmacology using advanced hiPSC-derived intestinal organoids. This article uniquely bridges practical assay design and translational research, offering unprecedented insight beyond current literature.

• Gepotidacin Efficacy in Treating Drug-Resistant Gonorrhea: P

  2026-05-16

  The referenced phase 2 clinical study demonstrates that single oral doses of gepotidacin, a novel bacterial type II topoisomerase inhibitor, achieve ≥95% microbiological cure in adults with uncomplicated urogenital gonorrhea, including strains resistant to existing antibiotics. This work highlights gepotidacin’s potential as an alternative therapy amid rising multidrug resistance, with important implications for future antibiotic stewardship strategies.

• ABT-888 (Veliparib): Applied Protocols for DNA Repair Inhibi

  2026-05-15

  ABT-888 (Veliparib) is a leading PARP inhibitor for synergizing DNA damage and enhancing chemotherapy efficacy, particularly in MSI and DNA repair-deficient tumor models. This guide synthesizes advanced workflows, troubleshooting strategies, and actionable insights to maximize ABT-888’s translational value in cancer research.

• EPI-001: Streamlining Androgen Receptor N-Terminal Inhibitio

  2026-05-15

  EPI-001, a potent androgen receptor N-terminal domain inhibitor, is redefining experimental workflows in prostate and triple-negative breast cancer research. Learn how optimized protocols and troubleshooting insights can maximize AR transcriptional activity inhibition and enhance translational impact.

• Dissecting N-Type Ca Channel Blockade by v-Agatoxin-IVA in N

  2026-05-14

  Sidach and Mintz's study rigorously re-examines the pharmacological selectivity of the spider toxin v-agatoxin-IVA on neuronal calcium channels, revealing nuanced differences in toxin sensitivity among P-, Q-, and N-type channels. Their findings refine functional channel classification and highlight challenges in employing toxin-based tools for dissecting calcium channel subtypes.

• BRCA2 Shields RAD51 Filaments from PARPi-Mediated PARP1 Rete

  2026-05-14

  This study uncovers a critical mechanistic link between BRCA2 function and cellular responses to PARP inhibition. The authors demonstrate that BRCA2 prevents PARP inhibitor-induced retention of PARP1 at DNA repair sites, thereby stabilizing RAD51 filaments and supporting homologous recombination, with direct implications for DNA repair deficiency targeting strategies.

• Drug Repurposing for DNA Repair Pathway Control in CRISPR Ed

  2026-05-13

  This study systematically screens clinically approved drugs to modulate DNA repair pathway choice following CRISPR-induced double-strand breaks in human stem cells. The findings provide a new framework for enhancing genome editing precision, synthetic lethality strategies, and disease modeling using pharmacological interventions.

• CGP 55845 Hydrochloride: Precision Tools for GABAB Synaptic

  2026-05-13

  Explore how CGP 55845 hydrochloride empowers advanced GABAB receptor antagonist research, enabling precise modulation of neurotransmitter release and synaptic transmission. This article offers a unique, protocol-focused perspective for optimizing in vitro assays and dissecting glial-neuronal interactions.

• Deferasirox Fe3+ Chelate: Applied Workflows for Iron Overloa

  2026-05-12

  Deferasirox Fe3+ chelate empowers researchers with high-purity, DMSO-soluble performance for beta-thalassemia and chronic anemia iron overload models. This article delivers hands-on protocols, workflow optimization, and troubleshooting tips, all grounded in recent literature and APExBIO’s trusted supply quality.

• Tetrahydromagnolol: Redefining CB2 Agonism in Metastatic Res

  2026-05-12

  Explore how Tetrahydromagnolol, a potent peripheral CB2 receptor agonist, uniquely advances cannabinoid receptor and anti-inflammatory research. This article offers in-depth analysis, mechanistic insights, and practical guidance for leveraging Tetrahydromagnolol in GPCR-driven metastasis and analgesic studies.

• Surface GlycoRNA-RBP Nanodomains Mediate Peptide Entry in Ce

  2026-05-11

  This study uncovers that RNA-binding proteins (RBPs) and glycoRNAs form distinct nanoclusters on the cell surface, serving as crucial entry points for cell-penetrating peptides like TAT. These findings expand the landscape of cell surface biology and offer new avenues for targeted delivery and interactome mapping.

• Mitochondrial Calcium Controls Ferroptosis via GPX4 Acetylat

  2026-05-11

  This study uncovers a mechanistic link between mitochondrial calcium uptake and the repression of ferroptotic cell death, mediated by GPX4 acetylation. The findings provide a new perspective on iron-dependent cell death regulation and suggest novel experimental strategies for ferroptosis research.

• LMO2–LDB1 Complex Drives AML: Mechanistic Insights and Metho

  2026-05-10

  This study reveals the oncogenic role of the LMO2/LDB1 protein complex in acute myeloid leukemia (AML), demonstrating that LDB1 is essential for AML cell proliferation and survival. Through genetic, proteomic, and functional genomics approaches, the research pinpoints LMO2/LDB1 as a critical regulator and potential therapeutic target in AML.

15287 records 4/1020 page Previous Next 12345 下5页 Last page